Maze Therapeutics MAZE Holds Steady Near Resistance A Quiet Signal of Stability US New Home Sales Slump in April as Elevated Mortgage Rates and Prices Dampen Demand EWBC Q1 2026 Earnings EPS Beats Estimates by 205 Stock Edges Lower Chinas DeepSeek AI Claims Breakthrough in LowCost ChipLimited Model Training